Japanese Patent Dispute Sees Teva In A New Role
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Generic drug maker Teva Pharmaceutical's recent move to sue Japanese pharma Kyowa Hakko Kogyo for patent infringement may be an indication of lawsuits to come, according to an industry expert
You may also be interested in...
Japan's Kirin, Kyowa Merge To Strengthen Biotechnology Focus
Kirin Holdings and Kyowa Hakko will seek to bring together each company's strength in biotech to create a global research and development-centered Japanese drug company. The two Tokyo-based companies announced a merger agreement Oct. 22, reflecting the ongoing consolidation of the Japanese drug industry
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).